Bibliography for: "NCKU Confers 5642 Degrees at 2009 Commencement Ceremony"

"NCKU Confers 5642 Degrees at 2009 Commencement Ceremony". Business Wire. FindArticles.com. 04 Dec, 2009. http://findarticles.com/p/articles/mi_m0EIN/is_20090606/ai_n31969958/

Business Wire

View more issues:

Articles in June 06, 2009 issue of Business Wire

• Facebookster Partners with Offerpal Media to Provide Leading Monetization Solution to New Social Applications
• General Growth Properties Announces New Director
• Utah Celebrates the First Graduating Class from the Nationally Recognized University of Southern Nevada—South Jordan Campus
• Largest Graduation Class in Northcentral University’s 13-Year History Called 21st Century Leaders
• International Diabetes Study Establishes GlycoMark as Definitive Test for Blood Sugar Swings in Seemingly Well-Controlled Patients
• VeroScience Presents Data on Newly FDA Approved Drug Cycloset at American Diabetes Association Annual Scientific Sessions
• In Investigational Studies, New Uses of JANUVIA™ (sitagliptin) in Combination with Other Diabetes Medicines Resulted in Significant Blood Sugar-Lowering Efficacy for Patients with Type 2 Diabetes
• Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
• Nearly 45,000 Participate in Susan G. Komen Global Race for the Cure®
• Calistoga Pharmaceuticals Reports Additional Clinical Responses in Ongoing Clinical Trial of CAL-101, an Isoform-Selective PI3 Kinase Inhibitor, Under Evaluation in Patients with Hematologic Malignancies
• NCKU Confers 5642 Degrees at 2009 Commencement Ceremony
• Results Presented at the ADA 69th Scientific Sessions Demonstrate that INCB13739, Incyte’s Oral 11beta-HSD1 Inhibitor, Significantly Improves Glycemic Control, Insulin Sensitivity and Total Cholesterol in Patients with Type 2 Diabetes
• Interim Analysis of Long-Term Data with ONGLYZA™ (saxagliptin) When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Presented at ADA Annual Scientific Sessions
• MoSys Acquires Prism Circuits, Inc.
• Medtronic Highlights New Advances in Development of Closed-Loop System for Diabetes Management
• Halozyme’s Phase 2 Insulin-PH20 Study Demonstrates Faster Insulin Absorption and Superior Glucose Control in Type 1 Diabetic Patients
• Photo from the Susan G. Komen Global Race for the Cure® on June 6, 2009 in Washington, D.C. is Available on Business Wire's Web Site and AP PhotoExpress